Press release
PacketFabric Secures $25 Million in Series B Funding From NantCapital and Updates Management Team
PacketFabric Closed Series B Funding for Expansion in Support of Accelerated Customer DemandsCulver City, Calif. (January 18, 2018) – PacketFabric, the highly scalable, connectivity-as-a-service platform and a member of the NantWorks ecosystem of companies, today announces it has secured $25 million in Series B funding from PacketFabric’s lead investor NantCapital to support the rapid growth and high demand for its services since its launch in 2017.
The company has grown rapidly since completing its seed round in 2015, and now operates a U.S. footprint that includes more than 150 Points of Presence (PoPs) in 17 metro markets with a terabit-scale backbone.
“As a scientist and entrepreneur, I am a firm supporter of market disruptive innovations,” states Dr. Patrick Soon-Shiong, Chairman and CEO of NantWorks. “This next-generation internet innovation of interconnectivity on demand will enable big data transport as a platform for multiple industries, and I am excited to fund this talented team at PacketFabric and their efforts to provide market-defining solutions. By eliminating barriers with its innovative solutions aimed at accommodating enterprises’ need for data transport, PacketFabric has the ability to change the landscape for many industries.”
The company also announces today that Chad Milam has joined PacketFabric as President and Chief Operating Officer, and a member of the board of directors. Chad has held the position of CTO at NantWorks and Mox Networks. Prior to NantWorks, Chad lead the Technical Infrastructure and Systems team at Teza Technologies, and the Global Infrastructure organization at Publicis Group S.A.
“With the proliferation of performance, security and capacity challenges, and adding on the recent development in net neutrality, the public internet is becoming an increasingly vulnerable venue for enterprise collaboration and service delivery,” says Chad Milam, President and COO of PacketFabric. “PacketFabric is the framework of how businesses securely connect, communicate and transact in the new digital reality.”
For more information about PacketFabric, visit www.packetfabric.com.
# # #
About PacketFabric
PacketFabric redefines how companies procure, consume, and manage their network connectivity services. Leveraging an innovative, entirely automated SDN-based network architecture and the latest in optical and packet switching technology, PacketFabric enables dynamic, real-time connectivity services between major carrier-neutral colocation facilities at terabit-scale. PacketFabric facilitates coast-to-coast connectivity between more than 150
premier colocation facilities across 17 U.S. markets, and enables simple, cost-effective, and scalable network deployment via its advanced Application Program Interface (API) and web-based portal. For more information, visit www.packetfabric.com or connect with PacketFabric on Twitter, LinkedIn and Facebook.
About NantWorks
NantWorks, LLC, founded by renowned physician scientist and inventor of the first human nanoparticle chemotherapeutic agent Abraxane®, Dr. Patrick Soon-Shiong, is the umbrella organization for the following entities: NantHealth, NantMobileHealth, NantOmics, NantBio, NantCell, NantPharma, NantCapital and NantCloud. Fact-based and solution-driven, each of NantWorks’ division entities operate at the nexus of innovation and infrastructure. The core mission of NantWorks is convergence and a systems approach to human biology: to develop and deliver a diverse range of technologies that accelerates innovation, broaden the scope of scientific discovery, enhance ground-breaking research, and improve healthcare treatment for those in need. NantWorks is building an integrated fact-based, genomically and proteomically-informed, personalized approach to the delivery of care and the development of next generation diagnostics and therapeutics for life threatening diseases such as Cancer, Infectious Diseases and Alzheimer’s. For more information please visit www.nantworks.com and follow Dr. Soon-Shiong on Twitter at @DrPatSoonShiong.
PacketFabric Contact:
iMiller Public Relations for PacketFabric
+1.866.307.2510
pr@packetfabric.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PacketFabric Secures $25 Million in Series B Funding From NantCapital and Updates Management Team here
News-ID: 907763 • Views: …
More Releases for NantWorks
NK Cell Therapy Market 2023 | Futuristic Trends- Nektar Therapeutics, Innate Pha …
The NK Cell Therapy report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The NK Cell Therapy research report recognizes and…
Cell Therapy Technologies Market Segmentation and Analysis by Recent Trends, Dev …
According to the report, the global cell therapy processing industry garnered $1.69 billion in 2018, and is estimated to reach $12.06 billion by 2026, growing at a CAGR of 27.8% from 2019 to 2026.
“Cell Therapy Processing Market by Offering Type (Products, Services, and Software), and Application (Cardiovascular Devices, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026″
Increase in the incidence of cardiovascular…
Global Respiratory Care Device Market Report Grooming Rapidly by Rising Trends a …
Respiratory care products refer to the various medical devices used for the treatment, diagnosis, and maintenance of patients suffering with pulmonary disorders. These respiratory care devices help in the diagnosis, preventive care, and treatment of various disorders including COVID-19, chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, asthma, allergies, sinusitis, nasal congestion, rhinitis, pneumonia, and other respiratory illnesses. The global respiratory care device market is expected to grow at a…
Global Cell Therapy Processing Market Analysis of The Current and Emerging Trend …
According to the report, the global cell therapy processing industry garnered $1.69 billion in 2018, and is estimated to reach $12.06 billion by 2026, growing at a CAGR of 27.8% from 2019 to 2026.
Increase in the incidence of cardiovascular diseases and surge in the demand for chimeric antigen receptor (CAR) cell therapy propel the global cell therapy processing market. However, poor demand from underdeveloped countries hinders the market growth. On…
Cell Therapy Processing Market to Reach $12.06 million With Top Key Players like …
Cell Therapy Processing Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/6446
According to the report, the global cell therapy processing industry…
Cell Therapy Processing Market top Companies Cell Therapies Pvt Ltd, Invitrx Inc …
The Global Cell therapy processing industry garnered $1.69 billion in 2018, and is estimated to reach $12.06 billion by 2026, growing at a CAGR of 27.8% from 2019 to 2026.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6446
Prime determinants of growth
Increase in the incidence of cardiovascular diseases and surge in the demand for chimeric antigen receptor (CAR) cell therapy propel the global cell therapy processing market. However, poor demand from underdeveloped countries hinders the…
